Matches in Wikidata for { <http://www.wikidata.org/entity/Q91194309> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q91194309 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91194309 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91194309 description "scientific article published on 19 January 2019" @default.
- Q91194309 description "wetenschappelijk artikel" @default.
- Q91194309 description "наукова стаття, опублікована 19 січня 2019" @default.
- Q91194309 name "Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study" @default.
- Q91194309 name "Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study" @default.
- Q91194309 type Item @default.
- Q91194309 label "Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study" @default.
- Q91194309 label "Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study" @default.
- Q91194309 altLabel "Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study" @default.
- Q91194309 altLabel "Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study" @default.
- Q91194309 prefLabel "Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study" @default.
- Q91194309 prefLabel "Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study" @default.
- Q91194309 P1433 Q91194309-B3102B8C-8E43-4E64-8C01-6C0CA42BE23E @default.
- Q91194309 P1476 Q91194309-3E7AC0F6-D72B-41F1-BF32-BAF7ED0B0663 @default.
- Q91194309 P1476 Q91194309-5749C9F1-CCF1-48DE-B486-5DF10411F5EF @default.
- Q91194309 P2093 Q91194309-0FB80C31-5497-4EAC-801F-BA0AD201F86C @default.
- Q91194309 P2093 Q91194309-1A5963F1-C3C5-455E-BB5E-E7C67B7FAC19 @default.
- Q91194309 P2093 Q91194309-2B2A70F3-92A5-4468-8DD9-4323CD998CA1 @default.
- Q91194309 P2093 Q91194309-40D7674F-79FC-44F6-BB58-219FB7052E31 @default.
- Q91194309 P2093 Q91194309-440E0BAB-C4DA-4564-BAB9-6E8F76862434 @default.
- Q91194309 P2093 Q91194309-5F764B2F-CF1C-4F00-88B7-90D49701CAE0 @default.
- Q91194309 P2093 Q91194309-6A04AA50-FBDE-4C83-B005-5B2CD25C6531 @default.
- Q91194309 P2093 Q91194309-962BC8A1-91CA-46CA-8F22-F85298A7D61A @default.
- Q91194309 P2093 Q91194309-9B12724B-5EC2-495C-9EB2-E5F25F1239EB @default.
- Q91194309 P2093 Q91194309-9E146BA1-4CBC-4991-8A97-1B7D3FCDAACF @default.
- Q91194309 P2093 Q91194309-C1F74225-8A4F-4051-AB86-EC0A172DF79C @default.
- Q91194309 P2093 Q91194309-FA3067DD-8DB2-47F4-9934-E3F527CEDE2C @default.
- Q91194309 P304 Q91194309-F9BC3C82-2C5D-48A0-A1CE-8CAE247B9EFA @default.
- Q91194309 P31 Q91194309-0FC53428-478E-4B14-9B36-532119BD8FB2 @default.
- Q91194309 P356 Q91194309-E1D02B07-AE79-41D1-B4BD-DECCBEA22974 @default.
- Q91194309 P433 Q91194309-3B9591BD-0913-4603-88F5-C8D3D9A2280C @default.
- Q91194309 P478 Q91194309-7A5B94C0-611C-4D86-BA1E-81854D1A746C @default.
- Q91194309 P577 Q91194309-E1C5ACB1-CD5E-4491-9E39-EA4437CF4743 @default.
- Q91194309 P577 Q91194309-F292B65D-128C-4C2F-BC41-AB1BD1B51DC5 @default.
- Q91194309 P698 Q91194309-41789581-26D8-472B-9C62-8ED4ADE1CAA6 @default.
- Q91194309 P698 Q91194309-91cd6dd5-0570-4a7f-9a07-e96b3480c652 @default.
- Q91194309 P921 Q91194309-01624D33-3D67-4B42-AA17-4EB5AB163703 @default.
- Q91194309 P921 Q91194309-7ACAF6EE-1F07-436A-B5A1-C1C361CAFB17 @default.
- Q91194309 P356 OLQ.0000000000000971 @default.
- Q91194309 P698 30985632 @default.
- Q91194309 P1433 Q15763556 @default.
- Q91194309 P1476 "Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study" @default.
- Q91194309 P1476 "Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study" @default.
- Q91194309 P2093 "Ashley Nenninger" @default.
- Q91194309 P2093 "Carol Tseng" @default.
- Q91194309 P2093 "Edward W Hook" @default.
- Q91194309 P2093 "Eugenia Henry" @default.
- Q91194309 P2093 "Jerri Swerdlow" @default.
- Q91194309 P2093 "Kimberly A Workowski" @default.
- Q91194309 P2093 "Matthew R Golden" @default.
- Q91194309 P2093 "Stephanie N Taylor" @default.
- Q91194309 P2093 "Sue Cammarata" @default.
- Q91194309 P304 "279-286" @default.
- Q91194309 P31 Q13442814 @default.
- Q91194309 P356 "10.1097/OLQ.0000000000000971" @default.
- Q91194309 P433 "5" @default.
- Q91194309 P478 "46" @default.
- Q91194309 P577 "2019-01-19T00:00:00Z" @default.
- Q91194309 P577 "2019-05-01T00:00:00Z" @default.
- Q91194309 P698 "30985632" @default.
- Q91194309 P921 Q101896 @default.
- Q91194309 P921 Q421713 @default.